Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-tvrd
/
Tvardi Therapeutics Ord Shs
TVRD
Add to Watchlist
1.890
USD
-0.010
-0.53%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
17.73M
Market Cap
0.29
P/E TTM
Tvardi Therapeutics Ord Shs
1.890
-0.010
-0.53%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Revenue Breakdown
Currency: USD
Updated: Tue, Dec 9
Currency: USD
Updated: Tue, Dec 9
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q3
FY2023Q2
FY2023Q1
FY2021
By Business
USD
Name
Revenue
Proportion
Other revenue
1.32M
51.50%
Collaborative revenue
1.20M
46.63%
Clinical compound revenue
48.00K
1.87%
Commercial supply revenue
0.00
0.00%
By Region
USD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
By Business
USD
Name
Revenue
Proportion
Other revenue
1.32M
51.50%
Collaborative revenue
1.20M
46.63%
Clinical compound revenue
48.00K
1.87%
Commercial supply revenue
0.00
0.00%